top of page

Search


A Guide to Patient Financial Assistance Programs
Patient financial assistance programs are implemented by drug manufacturers to help manage the cost of their drugs for patients.
Nov 11, 2024


Biosimilar Interchangeability: FDA Designation, Marketing Exclusivity, Guidance, and Future Trends
Biologics are regulated by the FDA and are approved under the 351(a) pathway with a Biologics License Application (BLA).
Nov 11, 2024


Understanding Limited Distribution Networks
Understanding which drugs are distributed through specialty pharmacies can be helpful for pharmacies, manufacturers, and payers
Nov 11, 2024


Introduction to Digital Therapeutics and Potential Payer Management
This article explains the ins and outs of digital therapeutics.
Apr 18, 2024


Paths to Approval: Understanding U.S. Regulatory Pathways for Drug Products
This article details the potential regulatory approval pathways.
Dec 24, 2021


Potential Market Exclusivity Granted During U.S. Regulatory Approval Process
This article explains potential data and market exclusivity granted during the U.S. regulatory approval process.
Dec 23, 2021


Understanding the Process for FDA Approval and Expedited Review
This article details the FDA evaluation process and expedited review designations.
Dec 22, 2021


Medical Drug Coding And Reimbursement 101
This article explains medical drug coding and reimbursement.
Dec 16, 2021


Drug Pricing Part 2: Generic Drug Pricing
This article explains generic drug pricing, associated terms, including MAC rates and lists, biosimilar pricing, and more.
Dec 15, 2021


Drug Pricing Part 1: Key Terms, Stakeholders, and Brand Drug Pricing Processes
This article answers the question, "how does branded drug pricing work?" defining associated terms such as average wholesale price, wholesal
Dec 14, 2021
bottom of page